Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Damian McNamara

  • News

    Early use of high-titer plasma may prevent severe COVID-19

    January 7, 2021

    Administering convalescent plasma that has high levels of antibodies against SARS-CoV-2 within the first 3 days of symptoms was associated with significantly lower chances of progression to severe COVID-19, new evidence demonstrates.

  • News

    Experts debate wisdom of delaying second COVID-19 vaccine dose

    January 5, 2021

    Another proposed strategy to extend the current supply of COVID-19 vaccines to more Americans involves splitting the current dosage of the Moderna vaccine in half.

  • News

    Complete blood count scoring can predict COVID-19 severity 

    December 30, 2020

    COVID-19 produces specific alterations in circulating blood cells that can be detected by a routine hematology analyzer.

  • 1
    News

    FDA grants emergency use for Moderna COVID-19 vaccine

    December 19, 2020

    “It’s incumbent upon all us healthcare professionals to put ourselves out there as supporting this vaccine and supporting people getting it.”

  • 1
    News

    FDA OKs emergency use of Pfizer COVID-19 vaccine

    December 12, 2020

    “Vaccinating healthcare workers, in particular, will be a model for the general public.”

  • News

    FDA safety alert: Face masks with metal can burn during MRI

    December 9, 2020

    Many face masks contain a nose wire or metal clip that helps the product conform to the face. Some masks contain metal nanoparticles, while others have coatings with silver or copper.

  • 1
    News

    Biden chooses California Attorney General Xavier Becerra to head HHS

    December 7, 2020

    Although his public health experience is limited, he served on the Congressional Ways and Means Committee overseeing health-related issues.

  • News

    PPE shortage crisis continues at most hospitals, survey shows

    December 7, 2020

    A majority of hospitals and health care facilities surveyed report operating according to “crisis standards of care.”

  • News

    CDC shortens COVID-19 quarantine time to 10 or 7 days, with conditions

    December 3, 2020

    The residual risk is approximately 1%, with an upper limit of 10%, when people quarantine for 10 days. .

  • News

    Moderna filing for FDA emergency COVID-19 vaccine approval, reports 94.1% efficacy

    November 30, 2020

    Vaccine efficacy remained consistent across different groups analyzed by age, race/ethnicity, and gender.

Previous1 2 3 4 5 6 … 8Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences